Lipfendra (enlicitide) is the first oral PCSK9 inhibitor, approved by the FDA in July 2026 at a list price of $315 a month.
News
Oregon's first legal psilocybin program tracked 346 participants for three months.
A 2026 Heidelberg study found boredom predicts hair-pulling episodes more reliably than anxiety
Developmental topographical disorientation causes people to get lost in their own homes despite normal intelligence.
A 2026 University of Oklahoma study in Cell Death & Differentiation reveals how macrophages drive breast cancer nerve growth in TNBC by
A world-first mitochondria injection therapy was used in a human eye in 2026. Here's what the Mount Sinai case found about safety and vision
A 2026 Nature Neuroscience study found structural brain changes visible by MRI at least 7 years before Alzheimer's amyloid plaques appear on PET
Dolly Parton dies at 80 in Nashville on August 25, 2026. Here is what she publicly shared about her health, grief
Science dropped 17,000 wallets in 40 countries to rank the most dishonest countries.
Hayden Panettiere alleged Neutrogena dropped her for discussing postpartum depression.
ER visits for the brutal 'scromiting' weed disorder jumped nearly 400% after October 2025.
A never-before-seen amyloid fold linked to the Flemish APP mutation may explain why amyloid-beta targets blood vessels in a rare